Pharmaceuticals
Cipla wants Novartis’s patents on respiratory drug revoked
30 Oct 2014
Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease
Merck oncology drug wins ‘breakthrough’ classification by US regulators
28 Oct 2014
Keytruda, Merck & Co's flagship new drug, forms part of a new generation of oncology treatments that use the body’s own immune system to attack and destroy tumours
CSL to acquire Novartis’ influenza vaccine unit
27 Oct 2014
Pfizer's $11-bn share repurchase ends chances of renewed bid for AstraZeneca
25 Oct 2014
US drugmaker Pfizer’s board yesterday authorised a new $11-billion share repurchase plan, which analysts say puts an end to speculations that it would renew its bid for British rival AstraZeneca
AbbVie calls off $55-bn acquisition of Shire over US tax rules
22 Oct 2014
AbbVie said the new US tax rules would keep it from gaining access to its overseas cash without having to pay hefty US taxes
.webp)
